VFA
IBB icon

Valeo Financial Advisors’s iShares Biotechnology ETF IBB Stock Holding History

Valeo Financial Advisors’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$313K Sell
1,646
-29
-2% -$4.99K 0.01% 614
2026
Q1 		$283K Sell
1,675
-15
-0.9% -$2.56K 0.01% 574
2025
Q4 		$285K Buy
1,690
+291
+21% +$47.3K 0.01% 640
2025
Q3 		$202K Buy
+1,399
New +$191K ﹤0.01% 758
2024
Q4 		– Sell
-1,417
Closed -$206K – 764
2024
Q3 		$206K Buy
+1,417
New +$205K 0.01% 648
2023
Q2 		– Sell
-2,135
Closed -$276K – 643
2023
Q1 		$276K Buy
2,135
+486
+29% +$63.6K 0.01% 465
2022
Q4 		$216K Buy
+1,649
New +$213K 0.01% 466
2022
Q2 		– Sell
-3,185
Closed -$415K – 572
2022
Q1 		$415K Buy
3,185
+881
+38% +$115K 0.02% 370
2021
Q4 		$352K Hold
2,304
– – 0.02% 382
2021
Q3 		$373K Sell
2,304
-400
-15% -$67.3K 0.02% 358
2021
Q2 		$442K Buy
2,704
+717
+36% +$110K 0.03% 283
2021
Q1 		$299K Sell
1,987
-109
-5% -$17.3K 0.01% 356
2020
Q4 		$318K Sell
2,096
-76
-3% -$10.9K 0.02% 322
2020
Q3 		$294K Sell
2,172
-3
-0.1% -$407 0.03% 260
2020
Q2 		$297K Buy
2,175
+11
+0.5% +$1.4K 0.03% 254
2020
Q1 		$246K Sell
2,164
-1,781
-45% -$205K 0.03% 259
2019
Q4 		$475K Buy
3,945
+2,955
+298% +$330K 0.05% 198
2019
Q3 		$99K Sell
990
-1,010
-51% -$106K 0.01% 439
2019
Q2 		$218K Sell
2,000
-547
-21% -$58.2K 0.03% 271
2019
Q1 		$285K Buy
2,547
+1,800
+241% +$197K 0.03% 226
2018
Q4 		$72K Sell
747
-84
-10% -$8.92K 0.01% 433
2018
Q3 		$86K Buy
831
+84
+11% +$9.89K 0.01% 432
2018
Q2 		$87K Hold
747
– – 0.01% 423
2018
Q1 		$80K Sell
747
-15
-2% -$1.66K 0.01% 404
2017
Q4 		$81K Buy
762
+120
+19% +$12.8K 0.01% 378
2017
Q3 		$71K Buy
+642
New +$68.6K 0.02% 346

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Valeo Financial Advisors's IBB Position: Q2 2026 in Review

Valeo Financial Advisors reduced its iShares Biotechnology ETF (IBB) stake by 1.7% in Q2 2026, selling an estimated $4.99K and leaving 1,646 shares worth $313K. The position accounts for 0.01% of the portfolio, ranked #614.

Valeo Financial Advisors first reported a position in IBB in Q3 2017 and has held it in 26 quarters since. The position peaked at $475K in Q4 2019. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Valeo Financial Advisors held 1,646 shares of iShares Biotechnology ETF worth $313K as of Q2 2026.
  • Valeo Financial Advisors sold 29 iShares Biotechnology ETF shares in Q2 2026, an estimated $4.99K.
  • iShares Biotechnology ETF made up 0.01% of Valeo Financial Advisors's portfolio in Q2 2026, its #614 holding.
  • Valeo Financial Advisors first reported a position in iShares Biotechnology ETF in Q3 2017 and has held it in 26 quarters since.
  • Valeo Financial Advisors's iShares Biotechnology ETF position peaked at $475K in Q4 2019.
  • 954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Valeo Financial Advisors's 13F filing for Q2 2026, filed 8 Jul 2026.